QUIDEL CORP /DE/
Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | |
|---|---|---|---|---|---|---|
| Revenue | $1.70B | $1.66B | $534.9M | $522.3M | $277.7M | $191.6M |
| Operating income | $906.1M | $1.06B | $92.7M | $95.9M | $9.6M | $19.2M |
| Net income | $704.2M | $810.3M | $72.9M | $74.2M | −$8.2M | $14.3M |
| Total assets | $2.43B | $1.87B | $910.9M | $806.4M | $935.3M | $388.3M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $1.93B | $1.33B | $559.8M | $425.6M | $227.1M | $200.6M |
| EPS (diluted) | $16.43 | $18.60 | $1.73 | $1.86 | $-0.24 | $0.42 |
| Shares out. | 42.3M | 41.9M | 39.4M | 34.9M | 33.0M | 32.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2021- Operating margin
- 53.3%
- Net margin
- 41.5%
- Return on equity
- 36.5%
- Return on assets
- 29.0%
- Return on capital (ROCE)
- 43.0%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $45.59
- Revenue growth (YoY)
- 2.2%
- Net income growth (YoY)
- −13.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2021- Accruals / assets
- −4.2%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 5 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 16, 2022
- Other material eventMay 6, 2022
- Results of operationsMay 4, 2022
- Results of operationsApr 7, 2022
- Results of operationsFeb 17, 2022
- Other material eventFeb 14, 2022
- Director / officer changeFeb 4, 2022
- Director / officer changeJan 27, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GJun 6, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 4FORM 4 SUBMISSIONJun 1, 2022
- 25-NSEMay 27, 2022
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.